Literature DB >> 2221436

hemofiltration reverses left ventricular dysfunction during sepsis in dogs.

A Gomez1, R Wang, H Unruh, R B Light, D Bose, T Chau, E Correa, S Mink.   

Abstract

Depressed left ventricular (LV) contractility in sepsis has been ascribed to the presence of circulating cardiodepressant substance (filterable cardiodepressant factor in sepsis [FCS]); however, this finding is controversial. The authors hypothesized that if a decrease in LV contractility indeed occurred due to a circulating depressant substance, then removal of this substance by hemofiltration would reverse by dysfunction. In this study, LV mechanics were examined before and after hemofiltration in anesthetized dogs during continuous intravenous infusion of live Escherichia coli. Left ventricular anterior-posterior and apex-base dimensions were measured by subendocardial ultrasonic crystal transducers implanted 4 weeks before the experiments. Left ventricular contractility was determined from the end-systolic pressure-dimension relationship. The slope of this relationship (Emax) is an index of contractility. After 4 h of sepsis, Emax was reduced by one half. Hemofiltration resulted in a return of Emax to control values. The FCS activity in the plasma was also assessed by the percent reduction in isometric contraction of electrically stimulated, isolated right ventricular trabeculae obtained from nonseptic dogs. The FCS activity reached a peak 4 h after sepsis and was reduced after 2 h of hemofiltration. The results show that during experimental sepsis, a circulating substance of less than 30,000 d produces a decrease in LV contractility and that this LV dysfunction may be improved by hemofiltration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221436     DOI: 10.1097/00000542-199010000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  18 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

2.  Effects of time interval for hemofiltration on the prognosis of severe acute pancreatitis.

Authors:  En-Qiang Mao; Yao-Qing Tang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  Ultrafiltration techniques and CPB: what we know and what we think we know.

Authors:  Bruce Searles
Journal:  J Extra Corpor Technol       Date:  2006-03

Review 4.  Renal replacement therapy review: past, present and future.

Authors:  Geoffrey M Fleming
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

5.  The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model.

Authors:  B Stein; E Pfenninger; A Grünert; J E Schmitz; A Deller; F Kocher
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

6.  Septic shock and multiple organ failure: treatment with haemofiltration?

Authors:  M Storck; W H Hartl; D Inthorn
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

7.  Purification methods: a way to treat severe acute inflammation related to sepsis?

Authors:  Anne Claire Lukaszewicz; Didier Payen
Journal:  Crit Care       Date:  2013-06-21       Impact factor: 9.097

8.  Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs.

Authors:  E F Yekebas; H Treede; W T Knoefel; C Bloechle; E Fink; J R Izbicki
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

Review 9.  Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense?

Authors:  M Schetz; P Ferdinande; G Van den Berghe; C Verwaest; P Lauwers
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

10.  Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury.

Authors:  Xiao Su; Chunxue Bai; Qunying Hong; Duming Zhu; Lixian He; Jianping Wu; Feng Ding; Xiaohui Fang; Michael A Matthay
Journal:  Intensive Care Med       Date:  2003-10-14       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.